first-line scheme+compound kushen injection
2023-063-KY
Approved small_molecule active
Quick answer
first-line scheme+compound kushen injection for Advanced Colorectal Carcinoma is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Advanced Colorectal Carcinoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active